10/06/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 10/6/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the UCLA SwabSeq COVID-19 Diagnostic Platform. The UCLA SwabSeq COVID19 Diagnostic Platform is authorized for use with upper respiratory specimens collected from individuals suspected of COVID-19 by their healthcare provider. (PDF)
.png)
No hay comentarios:
Publicar un comentario